About INNACCEL TECHNOLOGIES PRIVATE LIMITED
INNACCEL TECHNOLOGIES PRIVATE LIMITED is a Private Limited Company and was incorporated on Oct 01, 2012 in India. It is registered at Registrar of Companies, ROC Bangalore. Its registered address is AANAND TOWERS MUNICIPAL NO.4, RAJARAM MOHAN ROY ROAD,WARD N0 77,SAMPANGIRAMANAGAR, Bangalore, BANGALORE, Karnataka, India, 560025. Its corporate identification number is (CIN) U74900KA2012PTC066114 and its current status is Active. Its industry classification as per MCA is business Activities N.E.C. It had a team size of 71 employees as on Apr 01, 2026.
INNACCEL TECHNOLOGIES PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2025 as per records from Ministry of Corporate Affairs (MCA). INNACCEL TECHNOLOGIES PRIVATE LIMITED's authorised share capital is ₹1.15Cr and its paid up capital is ₹48L. The current board of directors of INNACCEL TECHNOLOGIES PRIVATE LIMITED comprises Siraj Dhanani and Sherif Mohammed Kottapurath.
INNACCEL TECHNOLOGIES PRIVATE LIMITED generated between ₹10 Cr and ₹50 Cr in revenue for the financial year ending on Mar 31, 2025.
Contact Details for INNACCEL TECHNOLOGIES PRIVATE LIMITED
- *****@innaccel.com
- Registered Address
- AANAND TOWERS MUNICIPAL NO.4, RAJARAM MOHAN ROY ROAD,WARD N0 77,SAMPANGIRAMANAGAR, Bangalore, BANGALORE, Karnataka, India, 560025
Brands associated with INNACCEL TECHNOLOGIES PRIVATE LIMITED
Principal Business Activity of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
C | Manufacturing | 13 | Manufacture of textiles | uo{ |
M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities | xoc |
Auditor Details of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
VARMA & VARMA | grfimxf | cllwjpz | thobpsj |
Documents of INNACCEL TECHNOLOGIES PRIVATE LIMITEDFY 25 Available
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form PAS-6 | Other eForm Documents | May 26, 2026 |
Form AOC-4 | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
List of share holders, debenture holders | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents) | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
e-Director?s Report | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
Form MGT-7A | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
Form PAS-3 | Other eForm Documents | Dec 03, 2025 |
Optional attachment(s)- if any | Other eForm Documents | Dec 03, 2025 |
Valuation Report from the valuer, if any; | Other eForm Documents | Dec 03, 2025 |
Financials of INNACCEL TECHNOLOGIES PRIVATE LIMITEDFY 25 Available
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 1961 | 3754 | 5835 | 3629 | 8574 |
Total Sales | 3999 | 4395 | 1525 | 1164 | 2771 |
Total Expenses | 6163 | 4676 | 3489 | 2553 | 6221 |
Operating Expenses | 2170 | 2281 | 7093 | 9275 | 2799 |
Employee Expenses | 5308 | 4600 | 4997 | 2286 | 3190 |
Operating Income (EBIT) | 7660 | 5518 | 4627 | 4283 | 8401 |
Interest Expenses | 1727 | 5589 | 1315 | 4337 | 3835 |
Expenses from other activities | 2377 | 4220 | 1674 | 5152 | 3010 |
EBITDA | 5680 | 5249 | 5500 | 9671 | 4156 |
Taxes | 5128 | 5200 | 5673 | 7136 | 8714 |
Net Profit | 7111 | 4473 | 6708 | 3061 | 1149 |
Balance Sheet | |||||
Assets | 5191 | 2429 | 4353 | 4503 | 5905 |
Accounts Receivables | 6662 | 9444 | 4549 | 8110 | 1924 |
Inventory | 5490 | 6792 | 6406 | 4700 | 3161 |
Liabilities | 6297 | 8203 | 2756 | 7118 | 7663 |
Total Debt | 1536 | 6860 | 5251 | 1277 | 1495 |
Accounts Payable | 9726 | 3756 | 9000 | 7064 | 7577 |
Equities | 5995 | 7001 | 2584 | 4593 | 2818 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 3787 | 4111 | 7398 | 1116 | 4882 |
EBIT Margin | 7120 | 9525 | 9621 | 9938 | 8506 |
Net Profit Margin | 3402 | 2120 | 2597 | 8813 | 2341 |
Return on Assets (ROA) | 6400 | 1311 | 9059 | 6362 | 2950 |
Return on Equity (ROE) | 7165 | 9913 | 6796 | 4643 | 5175 |
Return on Capital Employed | 4502 | 7372 | 6583 | 2030 | 3684 |
Return on Invested Capital | 8829 | 4276 | 3635 | 8999 | 7710 |
Efficiency Ratios | |||||
Asset Turnover | 8648 | 5591 | 4478 | 2310 | 4005 |
Receivables Turnover | 4928 | 7646 | 3633 | 2746 | 9188 |
Days Sales Outstanding | 8324 | 4363 | 3288 | 4262 | 1129 |
Inventory Turnover | 1519 | 4168 | 7318 | 5128 | 6649 |
Days Inventory Outstanding | 9995 | 4937 | 7893 | 2134 | 1536 |
Payables Turnover | 9614 | 7974 | 4715 | 9937 | 1769 |
Days Payables Outstanding | 9616 | 9251 | 2455 | 6360 | 1576 |
Liquidity Ratios | |||||
Current Ratio | 6765 | 5917 | 4605 | 2642 | 5643 |
Quick Ratio | 2165 | 2877 | 5327 | 3134 | 5805 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 5138 | 8036 | 8609 | 2179 | 7100 |
Debt Ratio | 1562 | 5435 | 5640 | 1167 | 1697 |
Interest Coverage Ratio | 3961 | 2237 | 4775 | 6526 | 8525 |
Debt Service Coverage Ratio | 8563 | 7029 | 3086 | 2117 | 4987 |
Net Debt/EBITDA | 3587 | 5728 | 9326 | 2555 | 7488 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 4641 | 9681 | 8673 | 8855 | 2592 |
Earnings Growth Rate (CAGR) | 1509 | 7774 | 8069 | 4007 | 2667 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 76% |
3 Year | 461 |
5 Year | 503 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 19% |
3 Year | 923 |
5 Year | 331 |
MSME Payment Delays by INNACCEL TECHNOLOGIES PRIVATE LIMITED
Credit Ratings of INNACCEL TECHNOLOGIES PRIVATE LIMITED
GSTIN Details of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Board of Directors and Signatories of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Board of Directors of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Oct 01, 2012 | 13 Years 9 Months | |
Director | Current | Oct 14, 2020 | 5 Years 9 Months |
Signatories of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Oct 01, 2012 | 13 Years 9 Months | |
Director | Current | Oct 01, 2012 | 13 Years 9 Months | |
Director | Current | Oct 19, 2020 | 5 Years 8 Months |
Cross Directorships of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
STAQU TECHNOLOGIES PRIVATE LIMITED CIN: U72300DL2015PTC281631, India, Active | 872 | 232 | 506 | 976 |
Legal Cases involving INNACCEL TECHNOLOGIES PRIVATE LIMITED
Employee Count of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Date | Employee Count |
|---|---|
Apr 26 | 71 |
Mar 26 | 650 |
Feb 26 | 340 |
Jan 26 | 445 |
Dec 25 | 828 |
Nov 25 | 795 |
Oct 25 | 843 |
Trademarks of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Patents of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Competitors & Alternates of INNACCEL TECHNOLOGIES PRIVATE LIMITED
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | ZOLL AEDs 1983, Chelmsford (United States), Acquired | Developer of medical devices and software solutions for emergency care | - | 60/100 | |
2nd | Developer of medical devices for critical care, obstetrics, and neonatology | $5.84M | 60/100 | ||
3rd | Developer of therapies for the treatment of pain and addiction | $248M | 59/100 | ||
4th | Manufacturer of AI-driven medical devices for critical care | $10M | 58/100 | ||
5th | Allied Medical 1982, Gurugram (India), Early Stage | Manufacturer of anesthesia and hospital equipment | $2.31M | 47/100 | |
6th | Brain Tunnelgenix Technologies 2006, Aventura (United States), Series B | Brain temperature tracking technology for healthcare, research, and performance optimization | $50.1M | 47/100 | |
7th | Airway Medix 2010, Warsaw (Poland), Public | Developer of medical devices for ventilated patients in intensive care units | - | - | 43/100 |
8th | Indwelling intravascular continuous blood glucose monitoring device | $6.59M | 41/100 | ||
9th | GlySure 2006, Abingdon (United Kingdom), Series C | Continuous glucose monitoring using optical fluorescence sensor | $24.5M | 40/100 | |
10th | Medivance 1998, Louisville (United States), Acquired | Non-invasive Temperature Management System | $59.2M | 40/100 |